Lumbar Intervertebral Disc Herniation

NCT ID: NCT02110186

Last Updated: 2014-04-10

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

195 participants

Study Classification

INTERVENTIONAL

Study Start Date

2012-07-31

Study Completion Date

2019-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to compare safety and outcomes of the following treatments of lumbar disc herniation: (1) discectomy with posterior dynamic stabilization with those of (2) discectomy alone or (3) discectomy with internal fixation and fusion.

Discectomy with posterior dynamic stabilization is proposed as the most effective treatment to improve range of motion, and to be similarly effective to discectomy alone and discectomy with internal fixation and fusion for other functional outcomes after surgery.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The purpose of this study is to compare outcomes of (1) discectomy with posterior dynamic stabilization with those of (2) discectomy alone or (3) discectomy with internal fixation and fusion.

Study aims are:

1. To demonstrate superiority of discectomy with posterior dynamic stabilization over discectomy alone and discectomy with internal fixation and fusion in range of motion at the operated level;
2. To demonstrate non-inferiority of discectomy with posterior dynamic stabilization compared to discectomy alone and discectomy with internal fixation and fusion in functional outcomes as measured by change in Oswestry Disability Index;
3. To compare radiological, clinical, patient-reported and safety outcomes among the three surgical approaches.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Lumbar Disc Herniation

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NON_RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Discectomy and dynamic stabilization

Discectomy with posterior dynamic stabilization

Group Type EXPERIMENTAL

Dynamic Stabilization

Intervention Type DEVICE

Discectomy

Intervention Type PROCEDURE

Discectomy alone

Discectomy

Group Type ACTIVE_COMPARATOR

Discectomy

Intervention Type PROCEDURE

Discectomy and fusion

Discectomy with internal fixation and fusion

Group Type ACTIVE_COMPARATOR

Discectomy

Intervention Type PROCEDURE

Instrumentation and fusion

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Dynamic Stabilization

Intervention Type DEVICE

Discectomy

Intervention Type PROCEDURE

Instrumentation and fusion

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Signed informed consent
* Age between 20 and 60 years inclusive
* Radiographic evidence of single level lumbar disc herniation
* Scheduled for single-level lumbar discectomy with or without fusion or dynamic stabilization
* Preoperative ODI ≥ 30
* Clinical symptoms consistent with lumbar disc herniation determined by history or physical exam:

* Radicular back or lower extremity pain and/or
* Decreased muscular strength and/or
* Abnormal sensation
* Involved disk at the spinal level between L2 and S1
* Failed to gain adequate symptom relief from at least one month of adequate non-operative treatment, except in patients with severe symptoms that require immediate surgery (at surgeon's discretion)
* Absence of significant symptomatic adjacent segment disk herniation

Exclusion Criteria

* Cauda equine syndrome
* Previous spinal surgery, except previous discectomy at the same segment
* Patients with other lumbar conditions that will, in the opinion of the investigator, interfere with clinical outcomes (e.g. spinal structural deformities, spinal fractures, ankylosing spondylitis, spinal tuberculosis, spinal infection, spinal tumors, symptomatic cervical spinal disease)
* Osteoporosis defined as T-score ≤ -2.5. BMD will be measured by DEXA performed on lumbar spine
* Systemic infection such as AIDS, HIV, and active hepatitis
* Recent history (less than 3 years) of chemical substance dependency or significant psychosocial disturbance, which may impact the outcome or study participation
* Participation in a clinical trial of another investigational drug or device within the past 30 days
Minimum Eligible Age

20 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Third Military Medical University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Qiang Zhou, MD. PhD.

Deputy Chair of the Department of Orthopedics, Chair of the Department of Spine Surgical Group

Responsibility Role PRINCIPAL_INVESTIGATOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

The Third Military Medical University/Southwest Hospital

Chongqing, , China

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

China

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Qiang Zhou, MD, PhD

Role: primary

86-13677669899

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TMMU-ORTHO-2012-001

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Flexion-Distraction Technique
NCT06886334 NOT_YET_RECRUITING PHASE1/PHASE2